- cafead   Aug 21, 2022 at 09:32: PM
via A group of investors — with the lead fund deliberately leaving its name out of the public view — just made an unsolicited financing offer of $150 million to Kymera Therapeutics, and it’s bound to raise a few eyebrows.
article source
article source